Formulation de diltiazem à absorption controllée

Patent europeic · EP0320097 · Stritgà

Inscripziun en il register

Numer da publicaziun
EP0320097
Numer da la dumonda
EP88309665
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
Stritgà
Scrittira da patent
Concedì
Annunzià
14-10-1988
Publitgà
14-06-1989
Concedì
04-06-2003
Stritgà
13-10-2008
Motiv
Durada maximala cuntanschida
Classas IPC
A61K 31/55 (2006.01)
A61K 9/00 (2006.01)
A61P 9/10 (2006.01)
Prioritad
IE 279087 16.10.1987
IE 279187 16.10.1987
IE 315887 20.11.1987
IE 82288 18.03.1988
Derivà da
EP98105888
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 20-10-2008

    Durada maximala cuntanschida

    Published in Swissreg on 20.10.2008

  2. 30-09-2003

    Represchentant inscrit

    Representative
    Patentanwälte, Schaad, Balass, Menzl & Partner AG, Dufourstrasse 101, 8034 Zürich

    Published in +pat+ No 18 in 2003

  3. 13-06-2003

    Concedì

    Published in +pat+ No 11 in 2003

Partidas

Possessur

Elan Corporation, Plc.

ELAN CORPORATION, Plc

Lincoln House, Lincoln Place, Dublin 2, IE

Represchentant

Patentanwälte Schaad, Balass, Menzl & Partner AG

Dufourstrasse 101, 8034 Zürich

Inventur

Geoghegan, Edward James

Athlone County Westmeath, IE

Mulligan, Seamus

Athlone County Westmeath, IE

Panoz, Donald Eugene

Tuckerstown Bermuda, IE

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.